Fresenius Kabi Competitors and Similar CompaniesClear all

Fresenius Kabi's competitors and similar companies include PainReform, Abiomed, Fresenius and Precise Group.

	Fresenius Kabi Fresenius Kabi is a healthcare company that specializes in medicines and technologies for infusion, transfusion, and clinical nutrition.	PainReform PainReform is a pharmaceutical company that develops products for the treatment of pain.	Abiomed Abiomed is a company providing medical devices for circulatory support.	Fresenius Fresenius is a healthcare group offering products and services for dialysis, hospitals, and outpatient treatment.	Precise Group Precise is a company that manufactures drugs.
Founding Date	Founding Date 1999	Founding Date 2007	Founding Date 1981	Founding Date 1912	Founding Date 1997
Type	Type Subsidiary	Type Private	Type Subsidiary	Type Public	Type Private
Tags	Tags Manufacturing & Industrial drug development medical devices nutrition pharma	Tags Healthcare biotech pharma	Tags Healthcare medical devices pharma	Tags Healthcare Manufacturing & Industrial drug development medical devices medtech nutrition pharma	Tags Manufacturing & Industrial drug development medical devices pharma
Locations	Locations Bad Homburg, DE HQ Buenos Aires, AR Sydney, AU Eugendorf, AT Graz, AT Linz, AT Schelle, BE see more	Locations Herzliya, IL HQ Tel Aviv Yafo, IL	Locations Danvers, US HQ Aachen, DE Tokyo, JP Halethorpe, US	Locations Bad Homburg vor der Höhe, DE HQ Buenos Aires, AR Buenos Aires, AR Sydney, AU Sydney, AU Eugendorf, AT Graz, AT see more	Locations Mumbai, IN HQ Dindori, IN Jhalawar, IN Mumbai, IN Navi Mumbai, IN Navi Mumbai, IN
Employees	Employees 42,079	Employees 7	Employees 2,00316% increase	Employees 175,202	Employees 5
Financial
Revenue (est.)	Revenue (est.) €7.9b (FY, 2022)	Revenue (est.) N/A	Revenue (est.) $1b (FY, 2022)	Revenue (est.) €22.9b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $188.2m (FY, 2022)	Cost of goods €16.1b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $843.6m (FY, 2022)	Gross profit €7.2b (FY, 2025)	Gross profit N/A
Net income	Net income €780m (FY, 2022)	Net income N/A	Net income $136.5m (FY, 2022)	Net income €1.6b (FY, 2025)	Net income N/A
Operating ⚠
Trademarks	Trademarks 1.2 k (Oct, 2023)	Trademarks N/A	Trademarks 8 (FY, 2019)	Trademarks N/A	Trademarks N/A
Trademarks Pending	Trademarks Pending 103 (Oct, 2023)	Trademarks Pending N/A	Trademarks Pending 5 (FY, 2019)	Trademarks Pending N/A	Trademarks Pending N/A